← All trials
NCT04578028
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2020
- Primary completion
- Jul 17, 2021
- Completion date
- Aug 29, 2021
- First posted
- Oct 8, 2020
- Last posted
- Nov 20, 2020
- Enrollment
- 112
- Arms / groups
- 10 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ono PharmaceuticalsLead sponsor
- ParexelCollaborator
- ParexelOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.